Biography

Robbert is a Managing Director and the Global Head of Healthcare at General Atlantic (GA), where he leads the firm’s healthcare investing strategy and serves on the Global Growth Equity Investment Committee. He has spent more than two decades at the firm and assumed the leadership role of GA’s healthcare efforts in 2014.

Since 2014, Robb has led or co-led 23 new healthcare investments (excluding follow-ons), representing over $4 billion in capital deployed. Over the past two years (2024–2025), he has deployed over $1 billion across investments including Vi Labs, Eventus WholeHealth, US Urology, and Legent Health. He has also led major investments such as Alignment Healthcare, Landmark Health, and Oak Street Health, with a long-term thematic focus on value-based care, technology enablement to shift care from higher- to lower-cost settings, specialty Rx access and affordability, and innovative health system partnership models.

Under his leadership, GA’s global healthcare investing team focuses on meaningful value creation, leveraging more than 80 value creation professionals to support portfolio companies across strategy, go-to-market, human capital, capital markets advisory, and M&A. He has delivered significant realized outcomes, including Alignment Healthcare (ALHC; $3.78 billion market cap), eviCore Healthcare ($3.6 billion acquisition by Express Scripts), Oak Street Health ($10.6 billion acquisition by CVS Health), Landmark Health (acquired by Optum Health), and OneOncology ($2.1 billion acquisition by Cencora and TPG).

Awards

Top Healthcare Investors: 2026, 2022, 2021